Cargando…

Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression

Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. It is characterized by the loss of androgen receptor (AR) signaling in neuroendocrine transdifferentiation, and finally, resistance to AR-targeted therapy. With the application of a new generation of potent AR inhibitors,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Zhengshuai, Cao, Qi, Guo, Bin, Zhao, Ye, Li, Xuechao, Lou, Ning, Zhu, Chenxi, Luo, Gang, Peng, Song, Li, Guohao, Chen, Ke, Wang, Yong, Ruan, Hailong, Guo, Yonglian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529746/ https://www.ncbi.nlm.nih.gov/pubmed/37196108 http://dx.doi.org/10.14336/AD.2023.0202

Ejemplares similares

Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma
por: Song, Zhengshuai, et al.
Publicado: (2020)

Pseudogene RACGAP1P activates RACGAP1/Rho/ERK signalling axis as a competing endogenous RNA to promote hepatocellular carcinoma early recurrence
por: Wang, Meng-Yao, et al.
Publicado: (2019)

Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects
por: Neubauer, Elisa, et al.
Publicado: (2016)

Long non‐coding RNA RACGAP1P promotes breast cancer invasion and metastasis via miR‐345‐5p/RACGAP1‐mediated mitochondrial fission
por: Zhou, Danmei, et al.
Publicado: (2020)

PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling
por: Chen, Hualin, et al.
Publicado: (2023)

Turning RacGAP into a RhoGAP
por: Tuma, Rabiya S.
Publicado: (2003)

HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way
por: Wu, Xianjian, et al.
Publicado: (2023)

Expression of aurora kinase A correlates with the Wnt‐modulator RACGAP1 in gastric cancer
por: Bornschein, Jan, et al.
Publicado: (2016)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features
por: Guo, Shuangping, et al.
Publicado: (2016)

EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation
por: Yin, Hubin, et al.
Publicado: (2022)

Mutations in the RACGAP1 gene cause autosomal recessive congenital dyserythropoietic anemia type III
por: Hernández, Gonzalo, et al.
Publicado: (2022)

P1475: MUTATIONS IN THE GAP DOMAIN OF RACGAP1 CAUSE DEVELOPMENTAL AND ERYTHROID DEFECTS IN ZEBRAFISH
por: Romero-Cortadellas, Lídia, et al.
Publicado: (2023)

Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
por: Zhang, Yan, et al.
Publicado: (2018)

IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2
por: Sperling, Florian, et al.
Publicado: (2022)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

The RacGAP β-Chimaerin is essential for cerebellar granule cell migration
por: Estep, Jason A., et al.
Publicado: (2018)

RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease
por: Wontakal, Sandeep N., et al.
Publicado: (2022)

Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis
por: Eid, Refaat A., et al.
Publicado: (2022)

Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway
por: Gu, Yang, et al.
Publicado: (2022)

Tum/RacGAP functions as a switch activating the Pav/kinesin-6 motor
por: Tao, Li, et al.
Publicado: (2016)

RACGAP1 is transcriptionally regulated by E2F3, and its depletion leads to mitotic catastrophe in esophageal squamous cell carcinoma
por: Zhao, Weifeng, et al.
Publicado: (2020)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

PRC1 and RACGAP1 are Diagnostic Biomarkers of Early HCC and PRC1 Drives Self-Renewal of Liver Cancer Stem Cells
por: Liao, Shixin, et al.
Publicado: (2022)

EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine
por: Barazeghi, Elham, et al.
Publicado: (2021)

circITGA7 Acts as a miR-370-3p Sponge to Suppress the Proliferation of Prostate Cancer
por: Luo, Gang, et al.
Publicado: (2021)

EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
por: Xiao, Gang, et al.
Publicado: (2019)

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome
por: Xu, Feng, et al.
Publicado: (2016)

Long non-coding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma
por: Xiao, Haibing, et al.
Publicado: (2017)

HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer
por: Wang, Jianqing, et al.
Publicado: (2019)

RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK
por: Zhang, Tianli, et al.
Publicado: (2022)

Androgen deprivation induces neuroendocrine phenotypes in prostate cancer cells through CREB1/EZH2-mediated downregulation of REST
por: Li, Wenliang, et al.
Publicado: (2023)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma
por: Li, Fan, et al.
Publicado: (2020)

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)

EZH2: An Accomplice of Gastric Cancer
por: Yu, Wuhan, et al.
Publicado: (2023)

lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter
por: Pu, Jian, et al.
Publicado: (2019)

Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
por: Cao, Jinfeng, et al.
Publicado: (2018)

EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation
por: Herviou, Laurie, et al.
Publicado: (2019)

1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis
por: Yan, Yutao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p127n97hvv153b5gq65s6nci4t